Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
CachexiaNSCLC
Interventions
DIETARY_SUPPLEMENT

Nutrifriend Cachexia

2 daily for 12 weeks

DIETARY_SUPPLEMENT

Isocaloric placebo

2 daily for 12 weeks

Trial Locations (14)

58185

Linkoping University Hospital, Linköping

42 000

GH Varaždin, Varaždin

23 000

GH Zadar, Zadar

10 000

CHC Sestre Milosrdnice, Zagreb

CHC Zagreb,, Zagreb

00128

Policlinico Universitario Campus Bio-Medico di Roma, Rome

00133

Policlinico Tor Vergata, Rome

00151

Azienda Ospedaliera San Camillo Forlanini, Rome

975 17

FNsP F.D. Roosvelta Banská Bystrica, Banská Bystrica

085 01

Nemocnica Sv. Jakuba, Bardejov

041 91

Východoslovenský onkologický ústav, Košice

071 01

NsP Štefana Kukuru Michalovce, Michalovce

081 81

FNsP J.A. Reimana, Prešov

751 85

Akademiska hospital, Uppsala

All Listed Sponsors
lead

Smartfish AS

INDUSTRY

NCT02515032 - Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia | Biotech Hunter | Biotech Hunter